Roger Ying

Roger Ying practices at NYU Langone - Tisch Hospital in New York, New York.

Roger Ying's NPI, 1912562620, was assigned on May 8, 2019. Roger Ying holds New York license PENDING.

Roger Ying's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Roger Ying's primary practice is NYU Langone - Tisch Hospital in New York, New York. Roger Ying is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Roger Ying practices. Vendor and product names are available with a free account.

Hospitalist is Roger Ying's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Roger Ying is licensed in New York.

CMS data shows 218 Medicare services from Roger Ying across 4 procedure codes in 2024, for 88 Medicare patients. Medicare paid $17,303 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Roger Ying in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Roger Ying's median patient age at 67, with 30% women.

In 2022, Roger Ying wrote 62 Medicare Part D claims. Every claim was for a generic drug. They cover 4 drugs, with $742 in total drug cost. In 2021, CMS named 121 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Roger Ying for performance year 2024, reported as part of a group. Roger Ying accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Roger Ying from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $31. It also lists 1 research payment totaling $500 in 2023.